Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

1.040 +0.050 (+5.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,728,612
Open 1.010
Bid (Size) 1.030 (4)
Ask (Size) 1.040 (2)
Prev. Close 0.9900
Today's Range 1.000 - 1.065
52wk Range 0.4471 - 1.540
Shares Outstanding 42,957,586
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2
Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $80 million to fund Phase 2. 
Via Benzinga

Performance

YTD
+6.8%
+6.8%
1 Month
+29.8%
+29.8%
3 Month
+33.4%
+33.4%
6 Month
+82.0%
+82.0%
1 Year
-25.7%
-25.7%

More News

Read More
Tuesday's session: gap up and gap down stocks
Via Chartmill
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Adicet Bio (ACET) Q2 Loss Widens 3%
Via The Motley Fool
Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
From Adicet Bio, Inc.
Via Business Wire
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Adicet Bio Appoints Michael Grissinger to the Board of Directors
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire

Frequently Asked Questions

Is Adicet Bio, Inc. - Common Stock publicly traded?
Yes, Adicet Bio, Inc. - Common Stock is publicly traded.
What exchange does Adicet Bio, Inc. - Common Stock trade on?
Adicet Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adicet Bio, Inc. - Common Stock?
The ticker symbol for Adicet Bio, Inc. - Common Stock is ACET on the Nasdaq Stock Market
What is the current price of Adicet Bio, Inc. - Common Stock?
The current price of Adicet Bio, Inc. - Common Stock is 1.040
When was Adicet Bio, Inc. - Common Stock last traded?
The last trade of Adicet Bio, Inc. - Common Stock was at 10/16/25 04:00 PM ET
What is the market capitalization of Adicet Bio, Inc. - Common Stock?
The market capitalization of Adicet Bio, Inc. - Common Stock is 44.68M
How many shares of Adicet Bio, Inc. - Common Stock are outstanding?
Adicet Bio, Inc. - Common Stock has 45M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.